I agree with you that NBIX has potential to be a great company, But don't look for this stock to return to its glory days in the next six to 12 months.
However, NBIX hasn't had a peaceful journey in the past year. NBIX has its share of sleepless nights. Of course, with last year's brou-ha with its poor execution in bringing FDA approvable status on indiplon's 5-, 10-, and 15-milligram capsules, investors are skittish in coming back, which only embolden Shorts to converge on NBIX.
When NBIX plunged 34 points in a single session, many investors came out with empty wallets to show for their trust.
The good news is NBIX uptrend has picked up steam in the past two weeks, with the company benefiting from good research news and analyst upgrades. Even the shorts have taken notice, as some have recently unwound their position. So far, the past few days, they have been orderly. We will see how orderly in the upcoming weeks.